FdaApplication

NDA 220837

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAPOTEX INC
application_typeNDA
approval_date2026-05-01

Products (1)

ProductActive ingredientStrengthDosage form
EVDITRABECTEDIN1MG/20ML (0.05MG/ML)SOLUTION;INTRAVENOUS

1 product